| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1118.6B | ¥1313.7B | -14.8% |
| Operating Income | ¥83.5B | ¥132.0B | -36.8% |
| Ordinary Income | ¥75.2B | ¥129.7B | -42.0% |
| Net Income | ¥54.8B | ¥91.4B | -39.7% |
| ROE | 5.5% | 9.5% | - |
FY2026 Q3 results show revenue of 111.9B yen (YoY -14.8%), operating income of 8.3B yen (YoY -36.8%), ordinary income of 7.5B yen (YoY -42.0%), and net income of 5.5B yen (YoY -40.0%). The consolidated performance reflects significant topline contraction with disproportionate profit decline. Revenue decreased by approximately 19.5B yen, while gross profit margin compressed to 16.9%, indicating pricing pressure or unfavorable product mix. Operating margin declined to 7.5% as selling, general and administrative expenses of 10.6B yen remained relatively fixed despite revenue decline. Non-operating expenses of 11.7B yen, primarily interest expenses of 0.7B yen, further pressured profitability. The effective tax rate of 28.6% resulted in net income of 5.5B yen, with basic EPS of 394.81 yen. Full-year company guidance projects operating income of 11.0B yen and net income of 7.0B yen with EPS of 504.34 yen, implying Q4 recovery expectations.
[Profitability] ROE of 5.5% declined from prior year, driven primarily by net profit margin compression to 4.9%. DuPont decomposition shows net profit margin of 4.9%, asset turnover of 0.508, and financial leverage of 2.22 times. Operating margin of 7.5% represents a substantial deterioration as fixed cost burden increased relative to shrinking revenue base. Gross profit margin of 16.9% falls below typical industry standards of 20%, suggesting market pricing pressure or product mix deterioration. Interest coverage ratio of 11.68 times indicates adequate debt servicing capacity despite margin pressures. [Cash Quality] Cash and deposits of 12.5B yen increased 31.4% YoY, though cash to short-term debt ratio of 0.32 times remains constrained. Working capital efficiency shows significant stress with days inventory outstanding of 252 days and days sales outstanding of 77 days, indicating prolonged cash conversion cycles. Work-in-process inventory of 32.1B yen represents an elevated proportion at 50% of total inventory, signaling production efficiency concerns. [Investment Efficiency] Total asset turnover of 0.508 times reflects operational efficiency below optimal levels. ROIC of 4.1% significantly underperforms capital cost expectations, indicating capital allocation requires reassessment. [Financial Health] Equity ratio of 45.0% provides moderate financial stability with total equity of 99.1B yen. Current ratio of 133.3% and quick ratio of 115.5% suggest adequate short-term liquidity on surface metrics. However, short-term debt concentration at 68.3% of total liabilities creates refinancing risk exposure. Interest-bearing debt totals 57.2B yen with short-term borrowings of 39.1B yen representing the majority, creating maturity structure vulnerability. Debt-to-capital ratio of 36.6% remains manageable but requires monitoring given the short-term concentration.
Cash and deposits increased 3.0B yen YoY to 12.5B yen, representing a 31.4% growth that provides incremental liquidity cushion. The cash accumulation occurred despite operating profit decline, suggesting potential asset monetization or financing activities contributed to the balance increase. Working capital composition reveals operational cash consumption pressures with accounts receivable of 23.5B yen and inventory of 13.7B yen requiring ongoing funding. Work-in-process inventory concentration at 32.1B yen indicates substantial cash tied up in production cycles, with the extended days inventory outstanding of 252 days confirming sluggish inventory turnover. Accounts payable of 17.2B yen provides 56 days of supplier credit, though the cash conversion cycle remains extended at approximately 273 days when combining receivables, inventory, and payables turnover. Short-term borrowings of 39.1B yen exceed cash balances by a factor of 3.1 times, resulting in the constrained cash coverage ratio of 0.32 times for short-term liabilities. This maturity mismatch between liquid assets and near-term obligations creates refinancing dependency that warrants close monitoring. The balance sheet structure suggests working capital optimization through inventory reduction and receivables acceleration represents the most direct path to improving cash flow generation and reducing external funding reliance.
Ordinary income of 7.5B yen versus operating income of 8.3B yen shows a net non-operating expense contribution of approximately 0.8B yen, indicating financial costs exceeded financial income. Non-operating expenses totaled 11.7B yen, primarily comprising interest expenses of 0.7B yen and other financial charges. Non-operating income of 3.5B yen included dividend income and gains on investment securities sales of 1.3B yen, representing approximately 3.1% of revenue. The presence of investment securities sales gains indicates a portion of ordinary income derives from non-recurring asset monetization rather than core operational performance. The extended working capital cycle with days inventory outstanding of 252 days and days sales outstanding of 77 days raises concerns about earnings converting to cash efficiently. Work-in-process inventory comprising 50% of total inventory suggests production-related accruals may be accumulating on the balance sheet. While direct operating cash flow data is unavailable for quarterly reporting, the combination of declining profitability, extended working capital cycles, and elevated work-in-process balances suggests earnings quality faces headwinds from operational efficiency deterioration and working capital consumption.
Revenue contraction risk with YoY decline of 14.8% continuing into Q3 and full-year guidance projecting 14% decline indicates demand weakness or market share loss requiring management attention. The extended cash conversion cycle of approximately 273 days combining inventory days of 252, receivables days of 77, and payables days of 56 creates significant working capital funding requirements and operational inefficiency. Refinancing and liquidity risk from short-term debt concentration with 39.1B yen of short-term borrowings representing 68.3% of total liabilities and cash coverage ratio of only 0.32 times exposes the company to funding market disruption and interest rate volatility.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE 5.5% versus industry median 5.0%, net profit margin 4.9% versus industry median 6.3%, operating margin 7.5% versus industry median 8.3%. The company's ROE marginally exceeds the manufacturing sector median, though profitability margins underperform peer medians by 1.4 percentage points on net margin and 0.8 percentage points on operating margin, indicating room for cost structure improvement. Financial Health: Equity ratio 45.0% versus industry median 63.8%, current ratio 133.3% versus industry median 284%. The company operates with notably higher financial leverage than sector peers, with equity ratio substantially below median reflecting more aggressive capital structure. Current ratio significantly trails industry median, consistent with the identified short-term liquidity constraints. Efficiency: Asset turnover 0.508 versus industry median 0.58, inventory days 252 versus industry median 109, receivables days 77 versus industry median 83. Asset utilization underperforms sector benchmarks, with inventory turnover representing the most significant deviation at more than double the industry median, confirming inventory management as a critical operational challenge. Growth: Revenue growth of -14.8% versus industry median +2.7% positions the company well below sector performance, with the decline representing substantial market share loss or end-market weakness requiring strategic response. Returns: ROIC 4.1% versus industry median 5.0%, indicating below-peer capital productivity that supports the identified need for capital allocation reassessment.
(Industry: Manufacturing sector, N=98 companies for most metrics, Comparison: 2025-Q3 fiscal periods, Source: Proprietary analysis)
Operational efficiency improvement represents the most critical value creation opportunity, with inventory days of 252 versus industry median of 109 and work-in-process concentration at 50% of inventory indicating substantial working capital release potential through production cycle optimization and inventory management discipline. Margin recovery pathway depends on addressing the gross margin compression to 16.9% through either pricing realization, favorable product mix shift, or cost reduction initiatives, as the current margin structure combined with relatively fixed SG&A creates operating leverage headwinds. Financial structure optimization requires attention to the short-term debt concentration and cash coverage ratio of 0.32 times, with working capital improvement providing the most sustainable path to reducing refinancing risk and interest rate exposure while supporting the elevated dividend payout ratio of 62.2%.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.